Comprehensive Analysis of the Subcutaneous Drug Delivery Devices Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Projected Compound Annual Growth Rate (CAGR) of the Subcutaneous Drug Delivery Devices Market from 2025 to 2034, and What Factors Influence It?
In recent years, the market size of subcutaneous drug delivery devices has significantly expanded. It is posed to escalate from $27.66 billion in 2024 to $29.77 billion in 2025, representing a compound annual growth rate (CAGR) of 7.6%. This impressive growth in the past period has been influenced by the augmenting occurrence of chronic illnesses, heightened demand for personal drug administration, an increase in diabetes and obesity cases, patients favoring hassle-free treatments, and growth of the elderly population.
In the following years, the market for subcutaneous drug delivery devices is projected to witness robust expansion. The market will surge to a value of $39.57 billion in 2029, experiencing a compound annual growth rate (CAGR) of 7.4%. The escalation throughout the estimation period can be credited to the growth in the biologics and biosimilars market, intensified acceptance of wearable drug delivery systems, the broadening of personalized treatment methods, enhancements in healthcare reimbursement strategies, and an increased focus on home healthcare. Key trends during the predicted period encompass the incorporation of digital health technologies, the creation of smart and connected devices, the surge in minimally invasive methods, advancements in needle-free injection technology, and the advent of artificial intelligence in the development of devices.
What Are the Primary Drivers Supporting the Growth of the Subcutaneous Drug Delivery Devices Market?
The growing instances of diabetes and cardiovascular conditions (CVD) are likely to fuel the expansion of the subcutaneous drug delivery devices market. The escalation in diabetes and cardiovascular conditions can be attributed to an aging demographic, poor eating habits, inactive lifestyle, being overweight, sociopolitical disparities, stress, environmental conditions, and insufficient access to preemptive healthcare. Devices delivering drugs subcutaneously are utilized in diabetes for supplying insulin and other medications for glycemic regulation and in cardiovascular cases to administer drugs such as anticoagulants or lipid-lowering agents. These offer a handy and controlled method for dealing with these chronic diseases. For instance, in April 2023, data from the British Diabetic Association, a charity organization in the UK for individuals with diabetes, unveiled that 4.3 million people in the UK are currently diagnosed with diabetes. The rate of diagnosed cases for 2021-22 rose by 148,951 compared to 2020-21, with nearly 2.4 million individuals at great risk of acquiring type 2 diabetes in the UK. Similarly in May 2024, according to the Centers for Disease Control and Prevention, a Federal agency based in the US, heart disease led to the demise of 702,880 people in 2022, corresponding to one in every five deaths. Hence, the surge in diabetes and cardiovascular diseases (CVD) is pushing the growth of the subcutaneous drug delivery devices market.
Explore Comprehensive Insights Into The Global Subcutaneous Drug Delivery Devices Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp
Who Are the Leading Players Fueling Growth in the Subcutaneous Drug Delivery Devices Market?
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.
What Are the Emerging Trends Shaping the Future of the Subcutaneous Drug Delivery Devices Market?
Prominent businesses in the subcutaneous drug delivery devices market are putting their resources into the creation of novel products, such as tiny digital fluid flow sensors, in order to improve the safety and accuracy of subcutaneous drug delivery by providing precise, customizable flow detectors for large-volume injection devices. These mini digital fluid flow sensors are compact tools designed to accurately gauge the flow velocity of liquids in small-scale uses, offering a digital feedback for precise supervision and regulation. As an example, in May 2024, Sensirion AG, a firm headquartered in Switzerland and specializing in environmental and flow sensors, introduced the SLD3x sensor platform. This series of sensors boasts highly precise digital fluid flow sensors whose features can be personalized, ensuring accurate flow measurement, detection of blockages, identification of in-line air bubbles, and liquid temperature monitoring. For large-scale medical device production, these tiny sensors are ideal, guaranteeing precise dosing and improved patient safety in subcutaneous drug delivery.
Secure Your Global Subcutaneous Drug Delivery Devices Market Report Now for Fast and Efficient Delivery!
Which Primary Segments of the Subcutaneous Drug Delivery Devices Market Are Driving Growth and Industry Transformations?
The subcutaneous drug delivery devicesmarket covered in this report is segmented –
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) Pen Needles: Standard Pen Needles, Safety Pen Needles
3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps
Which Regions Are Driving Growth in the Subcutaneous Drug Delivery Devices Market?
North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Subcutaneous Drug Delivery Devices Market Defined Across Different Regions?
Subcutaneous drug delivery devices are medical devices designed to administer medications directly into the subcutaneous tissue, the layer of fat and connective tissue just beneath the skin. These devices are used for the delivery of various drugs, including insulin, hormones, and biologics, providing a convenient and minimally invasive method of drug administration.
Browse Through More Similar Reports By The Business Research Company:
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Pharmaceutical Drug Delivery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Inhalation And Nasal Spray Generic Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
